Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease-Reference-Cited by-同舟云学术

Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease

Published:2019-01 Issue:1 Volume:7 Page:25-32
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Beldhuis Iris E.,Myhre Peder L.,Claggett Brian,Damman Kevin,Fang James C.,Lewis Eldrin F.,O’Meara Eileen,Pitt Bertram,Shah Sanjiv J.,Voors Adriaan A.,Pfeffer Marc A.,Solomon Scott D.,Desai Akshay S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Spironolactone for heart failure with preserved ejection fraction;Pitt;N Engl J Med,2014

2. Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial;Pfeffer;Circulation,2015

3. 2017 comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure;Ezekowitz;Can J Cardiol,2017

4. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure;Yancy;J Am Coll Cardiol,2017

5. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure;Ponikowski;Eur J Heart Fail,2016

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure with preserved ejection fraction epidemiology, pathophysiology, diagnosis and treatment strategies;International Journal of Cardiology;2024-10

2. AI hybrid survival assessment for advanced heart failure patients with renal dysfunction;Nature Communications;2024-08-08

3. Management of patients with heart failure and chronic kidney disease;Heart Failure Reviews;2024-07-29

4. Peak Tricuspid Regurgitation Jet Velocity and Kidney Outcomes in Patients With Heart Failure With Preserved Ejection Fraction;Kidney International Reports;2024-07

5. Targeting obesity for therapeutic intervention in heart failure patients;Expert Review of Cardiovascular Therapy;2024-06-02